Newton Investment Management
Other
Active
London, United Kingdom
4
141M
4
0.09
- Areas of investment
Summary
In 1978 was created Newton Investment Management, which is appeared as VC.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019.
Among the most successful fund investment fields, there are Therapeutics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Amphivena Therapeutics.
The typical case for the fund is to invest in rounds with more than 10 participants. The meaningful sponsors for the fund in investment in the same round are Tekla Capital Management, Qiming Venture Partners, NanoDimension.
Investor highlights
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 4
- Lead investments
- 0
- Rounds per year
- 0.09
- Investments by industry
- Biotechnology (2)
- Therapeutics (2)
- Health Care (1)
- Medical (1)
- Pharmaceutical (1) Show 11 more
- Investments by region
-
- United States (4)
- Peak activity year
- 2022
- Number of Unicorns
- 2
- Number of Decacorns
- 2
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Avg. valuation at time of investment
- 900M
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
Aspen Neuroscience | 09 May 2022 | Biotechnology, Medical, Pharmaceutical, Therapeutics | Early Stage Venture | 147M | United States, California, San Diego |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.